Christopher Michael Cashman, CEO at MARINUS PHARMACEUTICALS INC (MRNS), sold 8,142 shares at $3.13 ($25K) on 2019-01-28, disclosed to the SEC on 2019-01-30.
Open-market sale of $25k MRNS by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |